Evidence map›Paper›PMID 42298514›Full record

Trial reportBMC pulmonary medicine2026

Effect of post-discharge transitional care in patients with COPD: a multicenter single-blind randomised controlled trial.

Yukyung Park, Deog Kyeom Kim, Woo Jin Kim, Seon Sook Han, Yeon Jeong Heo, Da Hye Moon, Oh Beom Kwon, Myung Goo Lee, Ji Young Hong, Jung-Kyu Lee and 6 more

Abstract readRandomized Controlled TrialMulticenter Study
In one paragraph

Trial report in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Yukyung Park *Department of Health Policy and Management, Kangwon National University School of Medicine, Chuncheon, Republic of Korea.
Deog Kyeom Kim *Division of Pulmonary and Critical Care, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Woo Jin KimDepartment of Internal Medicine, Kangwon National University Hospital, Chuncheon, Republic of Korea.
Seon Sook HanDepartment of Internal Medicine, Kangwon National University Hospital, Chuncheon, Republic of Korea.
Yeon Jeong HeoDepartment of Internal Medicine, Kangwon National University Hospital, Chuncheon, Republic of Korea.
Da Hye MoonDepartment of Internal Medicine, Kangwon National University Hospital, Chuncheon, Republic of Korea.
Oh Beom KwonDepartment of Internal Medicine, Kangwon National University Hospital, Chuncheon, Republic of Korea.
Myung Goo LeeDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, 24253, Republic of Korea.
Ji Young HongDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, 24253, Republic of Korea.
Jung-Kyu LeeDivision of Pulmonary and Critical Care, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Eun Young HeoDivision of Pulmonary and Critical Care, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Hyun Woo LeeDivision of Pulmonary and Critical Care, Department of Internal Medicine, Seoul Metropolitan Government-Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
Yu Seong HwangDepartment of Health Policy and Management, Kangwon National University School of Medicine, Chuncheon, Republic of Korea.
Su Kyoung KimDepartment of Health Policy and Management, Kangwon National University School of Medicine, Chuncheon, Republic of Korea.
Chang Youl LeeDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Hallym University Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Chuncheon, 24253, Republic of Korea. doclcy@hallym.or.kr.
Heui Sug JoDepartment of Health Policy and Management, Kangwon National University School of Medicine, Chuncheon, Republic of Korea. joheuisug@gmail.com.

Funding

Ministry of Health and Welfare, Republic of Korea RS-2021-KH120369; RS-2025-02304587
6 · The paper itself

Abstract

backgroundChronic obstructive pulmonary disease (COPD) significantly impairs patient quality of life and places a substantial burden on healthcare systems. However, the effectiveness of transitional care in reducing healthcare utilisation and improving symptom control remains uncertain. This study aimed to evaluate the effectiveness of an evidence-informed transitional care program for hospitalised patients with COPD.

methodsIn this randomised controlled trial, 465 hospitalised patients with COPD from three South Korean university hospitals were block-randomised to intervention and control groups based on severity of airflow limitation (FEV1). The intervention involved a personalised care plan, including comprehensive assessment, patient education and training, telephone consultations, linkage to community services, home visits, and multidisciplinary case conferences. Participants were followed for 3 months after hospital discharge. Outcomes were analysed using an intention-to-treat approach. The primary outcome measures were readmission, respiratory symptoms, and treatment adherence. Mixed-effects models were used for repeated measures, and regression models were adjusted for baseline covariates.

resultsAt 3 months post-discharge, all-cause readmission was numerically lower in the intervention group than in the control group, but the difference was not statistically significant (adjusted OR 0.84; 95% CI 0.48-1.47). In exploratory cause-specific analyses, COPD-related readmissions were numerically fewer in the TCG than in the UCG (2 vs. 9 patients), although the small event counts limit interpretation. The intervention group showed significantly greater improvement in respiratory symptoms compared with the control group (modified Medical Research Council scale scores: adjusted mean difference - 0.41, p < 0.001; chronic obstructive pulmonary disease assessment test scores: - 3.38, p < 0.001). Treatment adherence also improved in the intervention group at 1 month, although this difference was not statistically significant at 3 months.

conclusionsPost-discharge transitional care may improve short-term symptom control and early inhaler adherence in patients with COPD, while its effect on readmission remains uncertain and warrants evaluation in adequately powered studies with longer follow-up.

trial registrationClinical Research Information Service (CRIS), No. KCT0007937, registered 24 November 2022-retrospectively registered.

Indexed as

Patient DischargePulmonary Disease, Chronic ObstructiveTransitional CareAgedFemaleHumansMaleMiddle AgedPatient Education as TopicPatient ReadmissionQuality of LifeRepublic of KoreaSingle-Blind MethodChronic obstructive pulmonary diseaseHealthcare utilizationHospital readmissionRandomised controlled trialTransitional care

Identifiers

PMID42298514
PMCPMC13495515

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.